This study extends the evaluation timepoint of previous studies investigating the effect of TGN-020 on ischemic stroke, providing further supportive evidence that acute inhibition of AQP4 after stroke is a viable therapeutic strategy. This evidence concerns the gene AQP4 and ischemic stroke.